Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
CDISC SDTM and ADaM for survival data - ppt download
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia | Leukemia
Kaplan-Meier estimates of (a) the primary endpoint of progression free... | Download Scientific Diagram
Progression-free survival as a surrogate endpoint in advanced neuroendocrine neoplasms in: Endocrine-Related Cancer Volume 24 Issue 9 (2017)
Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non–Small Cell Lung Cancer - Value in
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
Progression-free survival is a robust surrogate endpoint of overall survival in immunotherapy trials of hepatocellular carcinoma - Digestive and Liver Disease
Survival in oncology reimbursement decision-making | CMAR
Cumulative overall survival (OS) and progression-free survival (PFS)... | Download Scientific Diagram
Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists | BMC Cancer | Full Text
ROC analysis of the pretreatment AAPR by setting overall survival as... | Download Scientific Diagram
Surrogate endpoints for overall survival in randomised controlled trials of localised osteosarcoma: A meta-analytic evaluation | Scientific Reports
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival - Journal of Hepatology
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy? - Annals of Oncology
Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
Efficacy endpoints in Oncology
Endpoints Used in Clinical Trials Endpoint Definition Overall survival... | Download Table
Evolving Oncology Endpoints - IQVIA
ADMIRAL Trial: XOSPATA® (gilteritinib) Overall Survival
Clinical Trial Design - Endpoints - Quantics Biostatistics
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer† - Annals of Oncology
Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials | BMC Cancer | Full Text
図10 Overall survival (primary endpoint)
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
